Thomas Hansbrough, MD
Plastic Surgery within the Head & Neck · Baton Rouge, LANPI 1285623561
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $573 and has fallen 75.1% since, to $143 in 2024.
Across 137 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$490
- Optinose US, Inc.$409
- Regeneron Healthcare Solutions, Inc.$403
- Sanofi$312
- Alk-abello, Inc$80
- Novartis$72
- plus $294 from 11 others
What the payments were for
- Food & beverage$2,061100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 37 | $490 |
| Optinose US, Inc. | 35 | $409 |
| Regeneron Healthcare Solutions, Inc. | 21 | $403 |
| Sanofi | 16 | $312 |
| Alk-abello, Inc | 5 | $80 |
| Novartis | 4 | $72 |
| AbbVie | 4 | $60 |
| Phadia US Inc. | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 3 | $36 |
| Pfizer | 2 | $31 |
| Kaleo, Inc. | 2 | $28 |
| Smith+Nephew | 1 | $22 |
| Stryker | 1 | $22 |
| Intersect ENT, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
Too few plastic surgery within the head & neck providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 166 | $4,697 |
| Fluticasone Propionate | 272 | $3,418 |
| Doxycycline Monohydrate | 91 | $1,012 |
| Montelukast Sodium | 77 | $852 |
| Mupirocin | 30 | $609 |
| Cefdinir | 48 | $591 |
| Ipratropium Bromide | 23 | $524 |
| Ofloxacin | 27 | $456 |
| Fluconazole | 43 | $259 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $183 |
| Azithromycin | 17 | $59 |
| Prednisone | 26 | $44 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Baton Rouge
- Jon TraxlerBaton Rouge$6K
- Patricia ScallanBaton Rouge$4K
- Victoria PageBaton Rouge$3K
- Stanley PetersBaton Rouge$799
- Kenneth SandersShreveport$225K
- David RengifoShreveport$2K
- Sean WeissMetairie$891
- Christian HasneyNew Orleans$697
- Ronald AmedeeNew Orleans$560
- Akash AnandMetairie$339
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.